APA (7th ed.) Citation

Carolien N. H. Abheiden, Birgit S. Blomjous, Sylvia J. Kroese, Irene E. M. Bultink, Ruth D. E. Fritsch-Stork, A. Titia Lely, . . . Johanna I. P. de Vries. (2017). Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Carolien N. H. Abheiden, Birgit S. Blomjous, Sylvia J. Kroese, Irene E. M. Bultink, Ruth D. E. Fritsch-Stork, A. Titia Lely, Marjon A. de Boer, and Johanna I. P. de Vries. Low-molecular-weight Heparin and Aspirin Use in Relation to Pregnancy Outcome in Women with Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Cohort Study. Taylor & Francis Group, 2017.

MLA (9th ed.) Citation

Carolien N. H. Abheiden, et al. Low-molecular-weight Heparin and Aspirin Use in Relation to Pregnancy Outcome in Women with Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Cohort Study. Taylor & Francis Group, 2017.